Summary of project PR002091

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002091. The data can be accessed directly via it's Project DOI: 10.21228/M8B83W This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR002091
Project DOI:doi: 10.21228/M8B83W
Project Title:Non-Invasive Diagnosis of Moyamoya Disease Using Serum Metabolic Fingerprints and Machine Learning
Project Summary:Moyamoya disease (MMD) is a progressive cerebrovascular disorder that raises the risk of intracranial ischemia and hemorrhage. For a non-invasive diagnostic approach to MMD, we used nanoparticle-enhanced laser desorption/ionization mass spectrometry (LDI-MS) to analyze serum metabolic fingerprints (SMFs) in a validation cohort (MMD: 115/HC: 115) and a discovery cohort (MMD: 29/HC: 29).
Institute:Shanghai Jiao Tong University affiliated Renji Hospital
Last Name:Xu
First Name:Yudian
Address:Shanghai, 200127, P. R. China, Shanghai, Shanghai, 200127, China
Email:xuyd9r@sjtu.edu.cn
Phone:19370718762

Summary of all studies in project PR002091

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
Release
Date
VersionSamplesDownload
(* : Contains raw data)
ST003368 Non-Invasive Diagnosis of Moyamoya Disease Using Serum Metabolic Fingerprints and Machine Learning Homo sapiens Shanghai Jiao Tong University affiliated Renji Hospital MS* 2024-09-16 1 288 Uploaded data (411.2K)
  logo